Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 2021;71(3):209–49. Epub 20210204. doi: https://doi.org/10.3322/caac.21660. PubMed PMID: 33538338.

Article  PubMed  CAS  Google Scholar 

American Cancer Society. Key Statistics About Liver Cancer 2022. Available at https://www.cancer.org/cancer/liver-cancer/about/what-is-key-statistics.html. Accessed on February 22, 2024.

Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69(3):564–8. Epub 2019/07/31. doi: https://doi.org/10.1136/gutjnl-2019-318813. PubMed PMID: 31366455.

Article  PubMed  Google Scholar 

McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19(2):223–38. doi: 10.1016/j.cld.2015.01.001. PubMed PMID: 25921660.

Article  PubMed  PubMed Central  Google Scholar 

Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922–1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22. Erratum in: Hepatology. 2023;78(6):E105. doi: https://doi.org/10.1097/HEP.0000000000000621. PMID: 37199193; PMCID: PMC10663390.

American College of Radiology Committee on LI-RADS®. LI-RADS Ultrasound Surveillance v2024 Core. Available at https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-US-Surveillance-v2024-Core.pdf. Accessed on April 5, 2024.

Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130:417–422.

Article  PubMed  Google Scholar 

Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11(4):e1001624. doi: https://doi.org/10.1371/journal.pmed.1001624. PMID: 24691105; PMCID: PMC3972088.

Article  PubMed  PubMed Central  Google Scholar 

Chong N, Schoenberger H, Yekkaluri S, Fetzer DT, Rich NE, Yokoo T, Gopal P, Manwaring C, Quirk L, Singal AG. Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study. Aliment Pharmacol Ther. 2022;55(6):683–690. doi: https://doi.org/10.1111/apt.16779. Epub 2022 Feb 15. PMID: 35170052.

Article  PubMed  Google Scholar 

Simmons O, Fetzer DT, Yokoo T, Marrero JA, Yopp A, Kono Y, Parikh ND, Browning T, Singal AG. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45(1):169–177. doi: https://doi.org/10.1111/apt.13841. Epub 2016 Nov 8. PMID: 27862091; PMCID: PMC7207219.

Article  PubMed  CAS  Google Scholar 

Tiyarattanachai T, Fetzer DT, Kamaya A. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies. AJR Am J Roentgenol. 2022;219(3):445–452. doi: https://doi.org/10.2214/AJR.22.27405. Epub 2022 Apr 6. PMID: 35383486.

Article  PubMed  Google Scholar 

Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006;101(3):513–23. doi: AJG467 [pii]

Article  PubMed  CAS  Google Scholar 

Pocha C, Dieperink E, McMaken KA, Knott A, Thuras P, Ho SB. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study. Aliment Pharmacol Ther. 2013;38(3):303–12. doi: https://doi.org/10.1111/apt.12370. Epub 2013 Jun 10. PMID: 23750991.

Article  PubMed  CAS  Google Scholar 

Chong N, Schoenberger H, Yekkaluri S, Fetzer DT, Rich NE, Yokoo T, Gopal P, Manwaring C, Quirk L, Singal AG. Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study. Aliment Pharmacol Ther. 2022;55(6):683–690. doi: https://doi.org/10.1111/apt.16779. Epub 2022 Feb 15. PMID: 35170052.

Article  PubMed  Google Scholar 

Schoenberger H, Chong N, Fetzer DT, Rich NE, Yokoo T, Khatri G, Olivares J, Parikh ND, Yopp AC, Marrero JA, Singal AG. Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022;20(7):1561–1569.e4. doi: 10.1016/j.cgh.2021.06.012. Epub 2021 Jun 10. PMID: 34119640; PMCID: PMC8660956.

Article  PubMed  CAS  Google Scholar 

Hanna RF, Miloushev VZ, Tang A, Finklestone LA, Brejt SZ, Sandhu RS, Santillan CS, Wolfson T, Gamst A, Sirlin CB. Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma. Abdom Radiol (NY). 2016;41(1):71–90. doi: https://doi.org/10.1007/s00261-015-0592-8. PMID: 26830614.

Yoon Jin Lee, Jeong Min Lee, Ji Sung Lee, Hwa Young Lee, Bo Hyun Park, Young Hoon Kim, Joon Koo Han, and Byung Ihn Choi. Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging—A Systematic Review and Meta-Analysis. Radiology 2015 275:1, 97–109.

Screening population data reference MRI vs. US: Kim SY, An J, Lim YS, Han S, Lee JY, Byun JH, Won HJ, Lee SJ, Lee HC, Lee YS. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma. JAMA Oncol. 2017;3(4):456–463. doi: https://doi.org/10.1001/jamaoncol.2016.3147. PMID: 27657493; PMCID: PMC5470420.

Article  Google Scholar 

Lima PH, Fan B, Berube J, Cerny M, Olivie D, Giard JM, Beauchemin C, Tang A. Cost-utility Analysis of Imaging for Surveillance and Diagnosis of hepatocellular Carcinoma. AJR Am J Roentgenol. 2019;213(1):17–25. doi: https://doi.org/10.2214/AJR.18.20341. PMID: 30995098.

Kim YK, Kim YK, Park HJ, Park MJ, Lee WJ, et al. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma. Magn Reson Imaging 2014;32:610–8.

Article  PubMed  Google Scholar 

Chan MV, McDonald SJ, Ong YY, Mastrocostas K, Ho E, et al. HCC screening: assessment of an abbreviated non-contrast MRI protocol. Eur Radiol Exp 2019;3:49

Article  PubMed  PubMed Central  Google Scholar 

Park SH, Kim B, Kim SY, Shim YS, Kim JH, et al. Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort. Eur Radiol 2020;30:2302–11.

Article  PubMed  Google Scholar 

Vietti Violi N, Lewis S, Liao J, Hulkower M, Hernandez-Meza G, Smith K, Babb JS, Chin X, Song J, Said D, Kihira S, Sirlin CB, Reeder SB, Bashir MR, Fowler KJ, Ferket BS, Sigel K, Taouli B. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. Eur Radiol. 2020;30(11):6003–6013. doi: https://doi.org/10.1007/s00330-020-07014-1. Epub 2020 Jun 25. PMID: 32588209.

Article  PubMed  CAS  Google Scholar 

Kim DH, Yoon JH, Choi MH, Lee CH, Kang TW, Kim HA, Ku YM, Lee JM, Kim SH, Kim KA, Lee SL, Choi JI. Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC. J of Hepatology. 2024; doi: https://doi.org/10.1016/j.jhep.2024.03.048.

Article  PubMed  Google Scholar 

Sutherland T, Watts J, Ryan M, Galvin A, Temple F, et al. Diffusion-weighted MRI for hepatocellular carcinoma screening in chronic liver disease: direct comparison with ultrasound screening. J Med Imaging Radiat Oncol 2017;61:34–9.

Article  PubMed  Google Scholar 

Lee JY, Huo EJ, Weinstein S, Santos C, Monto A, et al. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma. Abdom Radiol (NY) 2018;43:1627-33. 27. Khatri G, Pedrosa I, Ananthakrishnan L, de Leon AD, Fetzer DT, et al. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018. J Magn Reson Imaging 2020;51:415 – 25.

Khatri et al. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: an equivalence study using LI-RADS v2018. J Magn Reson Imaging 2020;51:415–425.

Article  PubMed  Google Scholar 

Okubo H, Ando H, Sorin Y, Nakadera E, Fukada H, Morishige J, Miyazaki A, Ikejima K. Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C. PLoS One. 2018;13(4):e0196747. doi: https://doi.org/10.1371/journal.pone.0196747. PMID: 29709031; PMCID: PMC5927452.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brunsing RL, Chen DH, Schlein A, Wolfson T, Gamst A, Mamidipalli A, et al. Gadoxetate-enhanced abbreviated MRI for hepatocellular carcinoma surveillance: preliminary experience. Radiol Imaging Cancer 2019;1:e19001017.

Article  Google Scholar 

Vietti Violi N, Lewis S, Liao J, Hulkower M, Hernandez-Meza G, Smith K, et al. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. Eur Radiol 2020;30:6003–6013

Article  PubMed  CAS  Google Scholar 

Marks RM, Ryan A, Heba ER, Tang A, Wolfson TJ, Gamst AC, et al. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol 2015;204:527–535

Article  PubMed  Google Scholar 

Tillman BG, Gorman JD, Hru JM, Lee MH, King MC, Sirlin CB, et al. Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. Clin Radiol 2018;73:485–493

Article  PubMed  CAS  Google Scholar 

Park HJ, Kim SY, Singal AG, Lee SJ, Won HJ, Byun JH, et al. Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in highrisk patients. Liver Int 2021 Nov [Epub]. https://doi.org/10.1111/liv.15110

Gupta P, Soundararajan R, Patel A, Kumar-M P, Sharma V, Kalra N. Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol 2021;75:108–119

Article  PubMed